Suppr超能文献

维生素D补充剂能否成为心力衰竭的新疗法?来自干预研究数据的可能致病机制。

Could vitamin D supplements be a new therapy for heart failure? Possible pathogenic mechanisms from data of intervention studies.

作者信息

Dalbeni Andrea, Delva Pietro, Minuz Pietro

机构信息

Section of Internal Medicine, Department of Biomedical and Surgical Science, University of Verona, Policlinico "GB Rossi", P.le Scuro 1, 37134, Verona, Italy,

出版信息

Am J Cardiovasc Drugs. 2014 Oct;14(5):357-66. doi: 10.1007/s40256-014-0080-5.

Abstract

Vitamin D deficiency may play a role in the pathogenesis of chronic heart failure (HF), but whether giving patients supplements to raise vitamin D into the normal range improves their survival is not clear. It has been demonstrated that vitamin D deficiency is common in patients with HF, especially the elderly, in obese and in dark skinned people, and that low vitamin D levels are associated with adverse outcome. The epidemiological data have been confirmed by experimental data, which show that knockout mice for the vitamin D receptor developed myocardial hypertrophy and dysfunction. Data from interventional studies are scarce and discordant, and more research is urgently needed to confirm whether add-on supplementation therapy with vitamin D has a role in the management of patients with chronic HF.

摘要

维生素D缺乏可能在慢性心力衰竭(HF)的发病机制中起作用,但给予患者补充剂使维生素D水平升至正常范围是否能改善其生存率尚不清楚。已有研究表明,HF患者中维生素D缺乏很常见,尤其是老年人、肥胖者和肤色较深的人,且低维生素D水平与不良预后相关。流行病学数据已得到实验数据的证实,实验数据显示维生素D受体基因敲除小鼠会出现心肌肥大和功能障碍。干预性研究的数据稀少且不一致,因此迫切需要更多研究来证实维生素D补充疗法在慢性HF患者管理中是否有作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验